News
Company news, supply and partnership announcements.
Alvion Bio formalises leadership team as it scales Revalyxis™ platform Alvion Bio AB, the Lund-based supplier of amniotic fluid-derived mesenchymal stem cells (AF-MSCs), today confirmed its executive leadership team, with five of its founders stepping into formal roles as the company scales its Revalyxis™ cell platform. Justin Pierce takes the role of Chairman and Chief […]
Lund, Sweden › Alvion Bio AB today announced the launch of its new website at alvionbio.com, marking an important step in the company’s commercial development. The site introduces Alvion Bio’s role as an upstream supplier of amniotic fluid-derived mesenchymal stem cells (AF-MSCs) under the Revalyxis™ brand. Reflecting the company’s positioning — we make the cells, so others […]
Selected Revalyxis amniotic fluid stem cell banks are now available. Developers and researchers can submit an order enquiry to confirm availability and specifications.
Alvion Bio is building Revalyxis, a proprietary platform for the supply of amniotic fluid mesenchymal stem cells to therapy developers, clinicians and researchers.
